236 related articles for article (PubMed ID: 25575601)
1. The year in cardiology: heart failure 2014.
Voors AA; Ruschitzka F
Eur Heart J; 2015 Feb; 36(7):421-4. PubMed ID: 25575601
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic systolic heart failure].
Hasenfuse G; Anker SD
Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
[No Abstract] [Full Text] [Related]
3. The 2012 ESC Guidelines on Heart Failure.
Taylor J
Eur Heart J; 2012 Jul; 33(14):1703-4. PubMed ID: 22797149
[No Abstract] [Full Text] [Related]
4. The Year in Cardiology 2012: heart failure.
McDonagh TA
Eur Heart J; 2013 Feb; 34(7):499-502. PubMed ID: 23321348
[No Abstract] [Full Text] [Related]
5. Aldosterone antagonism in heart failure.
Richards AM; Nicholls MG
Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
[No Abstract] [Full Text] [Related]
6. MY APPROACH to treating heart failure with reduced ejection fraction.
Greenberg BH
Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
[No Abstract] [Full Text] [Related]
7. Heart failure: highlights from new consensus guidelines.
Young J
Cleve Clin J Med; 2000 Jan; 67(1):13-6. PubMed ID: 10645672
[TBL] [Abstract][Full Text] [Related]
8. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
van der Horst IC; Voors AA; van Veldhuisen DJ
Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
[No Abstract] [Full Text] [Related]
9. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
[No Abstract] [Full Text] [Related]
10. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
[No Abstract] [Full Text] [Related]
11. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
Mundhenke M
Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
[No Abstract] [Full Text] [Related]
12. [Heart failure].
Merx MW; Ertl G
Dtsch Med Wochenschr; 2011 Apr; 136(14):700-2. PubMed ID: 21448830
[No Abstract] [Full Text] [Related]
13. [Management of heart failure].
Jourdain P
Soins; 2013 Apr; (774):29-34. PubMed ID: 23697056
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
Weir RA; McMurray JJ; Puu M; Solomon SD; Olofsson B; Granger CB; Yusuf S; Michelson EL; Swedberg K; Pfeffer MA;
Eur J Heart Fail; 2008 Feb; 10(2):157-63. PubMed ID: 18242128
[TBL] [Abstract][Full Text] [Related]
15. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?].
Kitakaze M
Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136
[No Abstract] [Full Text] [Related]
16. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
17. Current challenges in the management of heart failure.
Komajda M
Circ J; 2015; 79(5):948-53. PubMed ID: 25877621
[TBL] [Abstract][Full Text] [Related]
18. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
[TBL] [Abstract][Full Text] [Related]
19. [Vasoactive and inotropic drugs in acute heart failure].
Ruiz-Laiglesia FJ; Camafort-Babkowski M
Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084
[TBL] [Abstract][Full Text] [Related]
20. Therapies for heart failure: a report from the Heart Failure Congress 2007.
Rabasseda X
Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E16. PubMed ID: 18297144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
